Reversión del Atracurium con dosis residuales de Neostigmine monitoreada con TOF WATCH

Abstract

Performs supreme importance to know the exact moment of the descurarizacion and the most suitable doses of the neostigmine and of the atropina, with the purpose of having positive results that they help to the condition hemodinamic without there are major alterations for the patient. Realized a study in 82 patients in the Enrique Sotomayor Hospital, which were monitored by TOF WATCH, with the purpose of reverting the atracurium with low doses of neostigmine. The 32 % of the patients did not need to be reverted, whereas 52 % was reverted in 6 +-2 minutes. 11 % had late reversion of which 2 % was due to hipotermia, the remaining ones owed to the previous managing of sulfate of magnesium. The reversion of low doses of neostigmine was useless in those patients managed with Sulfate of magnesium. Scarcely 21 patients had sialorrea, whereas 7 patients the bradicardia demonstrated. The managing of the patients with residual doses of neostigmine allowed that the time of the reversion should be acceptable, besides a decrease in the incident on the complications caused by the reversion.